All Stories

  1. Left Ventricular Remodelling in Aortic Stenosis
  2. Increases in Myocardial Workload Induced by Rapid Atrial Pacing Trigger Alterations in Global Metabolism
  3. CLINICAL IMPACT OF PERSISTENT LEFT BUNDLE BRANCH BLOCK AND PERMANENT PACEMAKER IMPLANTATION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT ON LEFT VENTICULAR FUNCTION
  4. RIGHT VENTRICULAR FUNCTION AFTER PERCUTANEOUS MITRAL VALVULOPLASTY IN MITRAL STENOSIS: DETERMINANTS FACTORS AND IMPACT ON LONG-TERM OUTCOME
  5. PATTERNS OF LEFT VENTRICULAR REMODELING IN PATIENTS WITH SEVERE AORTIC STENOSIS IN THE PARTNER TRIAL
  6. The aortic valve calcium nodule score (AVCNS) independently predicts paravalvular regurgitation after transcatheter aortic valve replacement (TAVR)
  7. Safety and efficacy metrics for primary nitinol stenting in femoropopliteal occlusive disease: A meta‐analysis and critical examination of current methodologies
  8. Feasibility of C-arm computed tomography for transcatheter aortic valve replacement planning
  9. Risk factors associated with the incidence and progression of mitral annulus calcification: The multi-ethnic study of atherosclerosis
  10. Long-Term Experience and Outcomes With Transcatheter Closure of Patent Foramen Ovale
  11. TCT-112 Left Ventricular Ejection Fraction Improves Less after Trans-Apical Transcatheter Aortic Valve Replacement Compared to a Trans-Femoral Approach
  12. TCT-114 Impact of Left Ventricular Function on Outcomes of Transcatheter Aortic Valve Replacement and Medical Therapy in Inoperable Patients with Aortic Stenosis: Insights from the Placement of Aortic Transcatheter Valves (PARTNER) Trial (Cohort B)
  13. Percutaneous Mitral and Aortic Balloon Valvuloplasty
  14. Associations between aspirin and other non-steroidal anti-inflammatory drugs and aortic valve or coronary artery calcification: The Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study
  15. Valvular Heart Disease
  16. Interpreting the Interpretations: The Use of Structured Reporting Improves Referring Clinicians' Comprehension of Coronary CT Angiography Reports
  17. PROGNOSIS OF PATIENTS WITH ISOLATED SEVERE AORTIC STENOSIS: ARE OUTCOMES SIMILAR FOR ALL PATIENTS WITH AN AORTIC VALVE AREA LESS THAN 1.0 CM 2 ?
  18. PREDICTORS OF RECURRENT NEUROLOGIC EVENTS IN PATIENTS WITH PATENT FORAMEN OVALE: INSIGHTS FROM THE CLOSURE I TRIAL
  19. NET ATRIOVENTRICULAR COMPLIANCE IS AN INDEPENDENT PREDICTOR OF MORTALITY IN MITRAL STENOSIS
  20. TCT-777 Non-Cerebrovascular Systemic Arterial Embolic Events from Paradoxical Embolization via Patent Foramen Ovale (PFO)
  21. TCT-778 Long-term Outcomes After Transcatheter Closure of Patent Foramen Ovale
  22. TCT-93 Relationship of Transcatheter and Surgical Aortic Valve Replacement with Left Ventricular Function in High-Risk Patients with Aortic Stenosis
  23. Medical, Surgical and Interventional Management of Hypertrophic Cardiomyopathy With Obstruction
  24. Slowing the Progression of Aortic Stenosis: The Emerging Role of Bisphosphonates
  25. Associations of LV Hypertrophy With Prevalent and Incident Valve Calcification
  26. First Experience With Transcatheter Valve-In-Valve Implantation for a Stenotic Mitral Prosthesis Within the United States
  27. RESTORING PLATELET FUNCTION EX VIVO BY ADDING FRESH PLATELETS WITHIN 24 HOURS OF A PRASUGREL 60 MG LOADING DOSE
  28. RISK FACTORS FOR PROGRESSION OF MITRAL ANNULUS CALCIFICATION: THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS
  29. Acute Stent Thrombosis: Technical Complication or Inadequate Antithrombotic Therapy?
  30. Balloon Aortic Valvuloplasty in the Transcatheter Aortic Valve Replacement Era
  31. Increased macrophage infiltration and neovascularization in congenital bicuspid aortic valve stenosis
  32. A novel clinical prediction rule for 30‐day mortality following balloon aortic valuloplasty: The CRRAC the AV score
  33. Bisphosphonate Use and Prevalence of Valvular and Vascular Calcification in Women
  34. Disseminated Intravascular Coagulation Complicating Epstein-Barr Virus Infection in a Cardiac Transplant Recipient: A Case Report
  35. Does Medical Therapy for Thoracic Aortic Aneurysms Really Work? Are β-Blockers Truly Indicated? CON
  36. The Effects of Race on Peak Oxygen Consumption and Survival in Patients With Systolic Dysfunction
  37. The Pathogenesis and Treatment of the Valvulopathy of Aortic Stenosis: Beyond the SEAS
  38. RECOMBINANT APOLIPOPROTEIN A-I MILANO DECREASES LEAFLET INFLAMMATION AND CALCIFICATION IN EXPERIMENTAL MODELS OF AORTIC STENOSIS
  39. BISPHOSPHONATES PREVENT OXIDIZED LOW-DENSITY LIPOPROTEIN-INDUCED EXPRESSION OF OSTEOGENIC MARKERS IN AORTIC VALVE MYOFIBROBLASTS
  40. RELATIONSHIPS BETWEEN LEFT VENTRICULAR MASS AND AORTIC VALVE CALCIFICATION: THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS
  41. Medical Therapy for Calcific Aortic Stenosis: The Use of Bisphosphonates
  42. Giant T-Wave Inversions and Extreme QT Prolongation
  43. Cardiovascular risk factors in patients with chronic kidney disease
  44. Academic Careers in Cardiovascular Medicine
  45. Reply
  46. Late medical versus interventional therapy for stable ST-segment elevation myocardial infarction
  47. Insights Into Degenerative Aortic Valve Disease
  48. Reply
  49. Effects of Gender on Peak Oxygen Consumption and the Timing of Cardiac Transplantation
  50. 283
  51. Effects of gender on peak oxygen consumption and the timing of cardiac transplantation
  52. Racial differences in peak VO2 and survival in heart failure patients
  53. Racial and Gender Differences in Peak Oxygen Consumption in Heart Failure Patients
  54. Kinetic evidence that the Na-PO4 cotransporter is the molecular mechanism for Na/Li exchange in human red blood cells
  55. Statins inhibit calcification of aortic valve interstitial cells